| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2024 | SAGE BIONETWORKS | 2901 3RD AVE STE 330 | SEATTLE | WA | 98121 | KING | USA | Cancer Biology Research | 001 | 5 | 12/4/2024 | NON-COMPETING CONTINUATION | $0 |
| 2025 | 2024 | SAGE BIONETWORKS | 2901 3RD AVE STE 330 | SEATTLE | WA | 98121 | KING | USA | Cancer Biology Research | 000 | 5 | 11/14/2024 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $776,200 ) |
| 2024 | 2024 | SAGE BIONETWORKS | 2901 3RD AVE STE 330 | SEATTLE | WA | 98121 | KING | USA | Cancer Biology Research | 002 | 5 | 9/10/2024 | NON-COMPETING CONTINUATION | $776,200 |
| 2024 | 2023 | SAGE BIONETWORKS | 2901 3RD AVE STE 330 | SEATTLE | WA | 98121 | KING | USA | Cancer Biology Research | 000 | 4 | 3/4/2024 | NON-COMPETING CONTINUATION | $0 |
| 2024 | 2023 | SAGE BIONETWORKS | 2901 3RD AVE STE 330 | SEATTLE | WA | 98121 | KING | USA | Cancer Biology Research | 001 | 4 | 4/23/2024 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $800,850 ) |
| 2023 | 2023 | SAGE BIONETWORKS | 2901 3RD AVE STE 330 | SEATTLE | WA | 98121 | KING | USA | Cancer Biology Research | 001 | 4 | 6/14/2023 | NON-COMPETING CONTINUATION | $800,850 |
| 2023 | 2022 | SAGE BIONETWORKS | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 000 | 3 | 2/7/2023 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2022 ( Subtotal = $801,343 ) |
| 2022 | 2022 | SAGE BIONETWORKS | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 002 | 3 | 7/7/2022 | NON-COMPETING CONTINUATION | $801,343 |
| 2022 | 2021 | SAGE BIONETWORKS | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Biology Research | 001 | 2 | 7/1/2022 | NON-COMPETING CONTINUATION | $0 |
| 2022 | 2021 | SAGE BIONETWORKS | 2901 3RD AVE STE 330 | SEATTLE | WA | 98121 | KING | USA | Cancer Biology Research | 000 | 2 | 1/26/2022 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $818,213 ) |
| 2021 | 2021 | SAGE BIONETWORKS | 2901 3RD AVE STE 330 | SEATTLE | WA | 98121 | KING | USA | Cancer Biology Research | 000 | 2 | 6/25/2021 | NON-COMPETING CONTINUATION | $818,213 |
|
 | Issue Date FY: 2020 ( Subtotal = $853,709 ) |
| 2020 | 2020 | SAGE BIONETWORKS | 2901 3RD AVE STE 330 | SEATTLE | WA | 98121 | KING | USA | Cancer Biology Research | 000 | 1 | 6/10/2020 | NEW | $853,709 |
|
|